WallStreetZenWallStreetZen

NASDAQ: PGNY
Progyny Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PGNY past earnings growth

How has PGNY's earnings growth performed historically?
Company
96.97%
Industry
-4.32%
Market
62.15%
PGNY's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PGNY's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
PGNY's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

PGNY past revenue growth

How has PGNY's revenue growth performed historically?
Company
38.34%
Industry
12.03%
Market
17.33%
PGNY's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PGNY's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PGNY's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PGNY earnings and revenue history

Current Revenue
$1.1B
Current Earnings
$62.0M
Current Profit Margin
5.7%

PGNY Return on Equity

Current Company
12.6%
Current Industry
-0.2%
Current Market
188%
PGNY's Return on Equity (12.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PGNY announces earnings.

PGNY Return on Assets

Current Company
8.8%
Current Industry
0.8%
PGNY is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PGNY Return on Capital Employed

Current Company
11.81%
Current Industry
2.2%
PGNY has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PGNY vs Health Information Service Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PGNY$1.09B$69.67M$62.04M+59.52%+74.65%
TXG$618.73M-$205.11M-$255.10M+33.43%N/A
EVH$1.96B-$24.79M-$142.26M+25.65%N/A
GDRX$750.27M$112.93M-$8.87M+24.63%N/A
CERT$354.34M$23.84M-$55.36M+16.70%N/A
View Top Health Information Service Stocks

PGNY earnings dates

Next earnings date
May 6, 2024

Progyny Earnings & Revenue FAQ

What were PGNY's earnings last quarter?

On Invalid Date, Progyny (NASDAQ: PGNY) reported Q4 2023 earnings per share (EPS) of $0.14, up 250% year over year. Total Progyny earnings for the quarter were $13.47 million. In the same quarter last year, Progyny's earnings per share (EPS) was $0.04.

If you're new to stock investing, here's how to buy Progyny stock.

What was PGNY's earnings growth in the past year?

As of Q2 2024, Progyny's earnings has grown 96.97% year over year. This is 101.29 percentage points higher than the US Health Information Services industry earnings growth rate of -4.32%. Progyny's earnings in the past year totalled $62.04 million.

What is PGNY's earnings date?

Progyny's earnings date is Invalid Date. Add PGNY to your watchlist to be reminded of PGNY's next earnings announcement.

What was PGNY's revenue last quarter?

On Invalid Date, Progyny (NASDAQ: PGNY) reported Q4 2023 revenue of $269.94 million up 25.95% year over year. In the same quarter last year, Progyny's revenue was $214.32 million.

What was PGNY's revenue growth in the past year?

As of Q2 2024, Progyny's revenue has grown 38.34% year over year. This is 26.31 percentage points higher than the US Health Information Services industry revenue growth rate of 12.03%. Progyny's revenue in the past year totalled $1.09 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.